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I. Introduction 
Correlative studies of the biochemical control 
mechanisms in the normal adrenal [ 1,2] and adreno- 
cortical carcinoma cells [3], have revealed various 
biochemical lesions both before and after the events 
leading to the cleavage of the cholesterol side chain. 
These metabolic lesions are responsible for the altered, 
but unique, ACTH-controlled system in these cells. 
These abnormalities have been observed at the level 
of plasma membrane [4], adenylate cyclase system 
[5,6], phosphodiesterase activity [7], and in the 
steroidogenic biosynthetic transformations of (20 S)- 
20-hydroxycholesterol [8,9] , pregnenolone, pro- 
gesterone and deoxycorticosterone [lo] to corti- 
costerone. During the course of these investigations it 
was observed [4] that, in an isolated adrenal cell and 
adrenocortical carcinoma cell, ACTH, in a unique 
way, stimulates the transport of deoxycorticosterone 
across the plasma membrane. That the phenomenon of 
stimulation by the polypeptide hormone was different 
from that of N6-0’ ‘-dibutyryl cyclic AMP was 
evidenced by the fact that although this cyclic nucleo- 
tide stimulated the membrane phenomenon in the 
normal cell, it failed to do so in the malignant cell [4]. 
This clearly established that the modes of action of 
ACTH and cyclic AMP on the plasma membrane were 
different and independent of each other. 
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2. Materials and methods 
Isolated adrenal and adrenocortical carcinoma 
cell preparations were made as previously described 
[l-3] . The method of incubation with double 
labeled radioactive precursors was as previously 
described [lo] . Incubation was carried out in 3 Teflon 
flasks. Each flask contained 20 ml isolated adrenal 
tumor cell suspension [3] prepared from 1.5 g 
adrenal tumor tissue or the same amount of cell 
suspension obtained from 16 adrenal glands of the rat 
[ 1,2] . In addition, to the appropriate cell suspension, 
the first flask contained a mixture of 25 /Xi of [ 1,2- 
3H2] deoxyc tic or osterone (specific activity 46.8 Ci/ 
mmol) and 1 /Xi of [4-i4C]deoxycorticosterone 
(specific activity 59.8 mCi/mmol) (3H/14C ratio 25.0); 
the second flask contained 25 /Xi of [3H]deoxy- 
corticosterone and cyclic AMP, cyclic GMP or cyclic 
IMP, and the third flask 1 /Xi of [4-i4C]deoxycorti- 
costerone. The incubation was continued for 150 min 
and the reaction was stopped by the addition of 
75 ml of methylene chloride into each flask. The 
contents of the second flask were mixed with contents 
of the third flask. To the reaction mixture of each 
flask, 10 mg of corticosterone and 15 mg of deoxy- 
corticosterone were added and the products processed 
identically. 
The experiment with the preloading of the cells 
with [3H]deoxycorticosterone was conducted as 
previously described [ 1 l] . Twenty millilitres of sus- 
pended cells obtained from adrenal glands of 32 rats 
were preincubated for 30 min with 50 @Ji of [3H] dec- 
xycorticosterone. The cell pellet obtained by centrifuga- 
tion was washed with 20 ml Krebs-Ringer-bicarbonate 
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Table 1 
Effect of CAMP on the incorporation of [ sH] deoxycorticosterone into 
corticosterone in normal isolated adrenal cells 
Crystallization ‘H/“C ratio of corticosterone in % Stimulation 
Flask 1 Flask 2 + 3 
1st 25.33 36.47 
2nd 25.61 37.13 
3rd 26.23 37.50 44 
The ‘H/14C ratios of the products obtained after the incubation of [ 1,2-sH,, 
4-“Cl -deoxycorticosterone with isolated adrenal cells. Conditions of the experi- 
ment were similar to the experiment in table 2. 
buffer which contained albumin and glucose, and 
the cells were resuspended in 60 ml of Krebs-Ringer- 
bicarbonate buffer containing albumin and glucose. 
The cell suspension was divided into three flasks. The 
control flask contained 20 ml of suspended cells and 
[3H]deoxycorticosterone, and the other two flasks 
contained cyclic GMP or cyclic IMP. The incubation 
was carried out for 150 min and the reaction mixture 
processed as mentioned earlier. 
Deoxycorticosterone and corticosterone were 
purified by thin-layer chromatography. The isolated 
deoxycorticosterone was acetylated [lo], further 
purified by thin-layer chromatography [9,10], and 
crystallized from acetone-n-hexane to constant 
specific activity. The purified corticosterone was 
crystallized from acetone-ligroin until the specific 
activity and (3H/‘4C) ratio were constant. 
3. Results and discussion 
The present investigation shows that cyclic AMP, 
cyclic GMP and cyclic IMP, in contrast to the tumor 
cell, stimulate the incorporation of deoxycorticosterone 
into corticosterone in isolated adrenal cell (table l-3). 
Table 2 
Effect of cGMP on the incorporation of [‘Hldeoxycorticosterone into corticosterone in 
normal isolated adrenal and adrenocortical carcinoma cells 
Isolated cells from Crystallization sH/“C ratio of corticosterone from % Stimulation 
Flask 1 Flask 2 + 3 
Normal adrenal 1st 25.18 43.05 
2nd 25.63 42.33 
3rd 25.97 43.70 68 
Adrenocortical 
carcinoma 
1st 25.03 26.13 
2nd 25.88 27.17 
3rd 26.70 27.76 0 
The ‘H/“C ratios of corticosterone obtained after the incubation of [ 1 ,2-3H,, 4-“Cl, 
deoxycorticosterone with isolated adrenal and adrenocortical carcinoma cells. Incubation was 
carried out in 3 flasks containing 20 ml isolated adrenal or adrenocortical carcinoma cell pre- 
paration as mentioned in Materials and methods. Flask 1 contained a mixture of [ 1,2-3H,]deoxy- 
corticosterone (25 PCi) + (4-“Cldeoxycorticosterone (1 nCi) (‘H/Y ratio 25.00; flask 2 con- 
tained [1,2-3H,]deoxycorticosterone (26 PCi) + cGMP (10 mM) and flask 3 contained [4-“Cl 
deoxycorticosterone (1 r&i). The incubation was 2.5 h and the reaction was stopped by the 
addition of 75 ml methylene chloride to each flask. The contents of the second and third flask 
were mixed and corticosterone isolated as described in Materials and methods. 
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Table 3 
Effect of cIMP on the incorporation of [‘Hldeoxycorticosterone into corticosterone in 
normal isolated adrenal and adrenocortical carcinoma cells 
Isolated cells from 
Normal adrenal 
Crystallization 
1st 
2nd 
3rd 
3H/‘4C ratio of corticosterone in 
Flask 1 Flask 2 + 3 
25.18 88.13 
25.63 89.28 
25.97 90.89 
% Stimulation 
250 
Adrenocortical 1st 25.03 25.44 
carcinoma 
2nd 25.88 25.12 
3rd 26.70 25.63 0 
The 3H/‘4C ratios of the products obtained after the incubation of [ l,2-3H,, 4-“Cldeoxy- 
corticosterone with isolated adrenal and adrenocortical carcinoma cells. Conditions of the 
experiment were similar to the experiment in table 2. 
The evidence has been provided that this requires the purified and crystallized as the 2 1 -acetyl derivative. The 
interposition of the plasma membrane, since preloading results in table 4 show there was still about 90% of 
the cells eliminates cyclic nucleotides stimulation. To the unused substrate, deoxycorticosterone, in the 
eliminate the possibility that the nonstimulatory effect incubation system. 
of cyclic nucleotides in the preloaded cells might be In conclusion, the results of the present investiga- 
due to the insufficient availability of the substrate, tion, together with the previous study [4], indicate 
deoxycorticosterone, the latter steroid was isolated, ACTH, cyclic AMP, cyclic GMP and cyclic IMP, the 
Table 4 
Effect of cGMP and cIMP on the incorporation of [“Hldeoxycorticosterone 
into corticosterone in preloaded normal isolated adrenal cells 
Compound Crystallization 3H dpm of compound from 
Control +cGMP +cIMP 
Deoxycorticos- 
terone acetate 
Corticosterone 
1st 182 192 168 968 178 330 
1st 21 820 18 640 20 100 
2 nd 20 130 17 090 19 250 
3rd 18 040 16 600 18 210 
The total ‘H-dpm of the products (and their derivatives) obtained after the incuba- 
tion of [ 1,2-“H,]deoxycorticosterone with isolated adrenal cells. Twentyinilli- 
liters of isolated adrenal cell preparation obtained from adrenals of 32 rats was 
preincubated with 50 rCi of [ 1,2-aH2]deoxycorticosterone for 30 min. The cells 
were washed and resuspended in 60 ml of Krebs-Ringer-bicarbonate buffer con- 
taining albumin and glucose. Flask I, used as a control, contained 20 ml aliquot 
of cell suspension, flask 2 contained 20 ml aliquot of cell suspension + cGMP 
(IO mM), whereas to flask 3, in addition to cell suspension, (20 ml) was added 
cIMP (10 mM). The incubation was for 2.5 h and the reaction was stopped by the 
addition of 75 ml methylene chloride to each flask. Deoxycorticosterone and 
corticosterone were isolated and purified by thin-layer chromatography and the 
crystallized to constant specific activity as described earlier. 
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agents which stimulate steroidogenesis [1 ] in an 
isolated adrenal cell also stimulate the transport 
phenomenon of deoxycorticosterone across the plasma 
membrane. In the tumor, however, ACTH stimulates 
the membrane effect [4] but the cyclic nucleotides are 
incapable of doing so. Previously, it has been shown 
[3] that neither ACTH nor cyclic AMP, cyclic GMP or 
cyclic IMP, are able to stimulate corticosterone 
synthesis in the tumor cells. Recently [ 12,131 the 
protein kinase enzyme, which binds cyclic AMP but is 
unable to activate the cyclic AMP-dependent phos- 
phorylation process, has been isolated and purified 
from the adrenocortical carcinoma. It has been 
proposed that the lack of cyclic AMP-stimulated 
steroidogenesis is due to the defective protein kinase 
enzyme [ 12,131. It is therefore quite probable that 
the inability of the cyclic nucleotides to influence 
membrane transport process in the malignant cell is 
due to the lack of the cyclic nucleotide-dependent 
phosphorylation phenomenon. 
These studies, therefore, indicate that not only the 
two types of membrane transport processes are 
different in the malignant and normal cell, but they 
also indicate that the phenomenon of ACTH-activated 
transport system is quite distinct from the cyclic 
nucleotide-stimulated system in a normal cell. Since 
in the tumor, where there is a defective protein kinase 
system, ACTH does stimulate but the cyclic nucleo- 
tides do not stimulate the membrane-dependent 
transport system, this indicates that the ACTH-stimulated 
membrane phenomenon does not involve the obliga- 
tory protein kinase system but for the cyclic nucleotide- 
activated system this is a preprequisite. These factors 
have been depicted in fig. 1. 
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